Gul Asma, Halim Sobia Ahsan, Khan Ajmal, Khan Rasool, Xian-Dao P A N, Zafar Salman, Akbar Noor, Jan Afnan, Muhsinah Abdullatif Bin, Gojayev Anar, Al-Harrasi Ahmed
Institute of Chemical Sciences, University of Peshawar, Peshawar, 25120, Pakistan.
Natural and Medical Sciences Research Center, University of Nizwa, P. O. Box-33, Postal Code-616, Birkat Al-Mauz, Nizwa, Sultanate of Oman.
Heliyon. 2024 Apr 27;10(9):e30435. doi: 10.1016/j.heliyon.2024.e30435. eCollection 2024 May 15.
The synthesis of a new series of thiadiazine thiones including 5-(2-hydroxyethyl)-3-alkyl/aryl-1, 3, 5-thiadiazine-2-thiones (-), 5-(2-hydroxypropyl)-3-alkyl/aryl-1, 3, 5-thiadiazine-2-thiones (-), 3,5-dipropyl-1, 3, 5-thiadiazine-2-thione () and (2-(5-alkyl/aryl-6-thioxo-1, 3, 5-thiadiazine-3-yl) alkyl acetate/benzoate) (-) was accomplished one pot reaction. The structures of the synthesized compounds were characterized through NMR and Mass spectrometry. The anti-nociceptive activity of compounds was performed on BALB/C mice by hot plate method, where compounds , (50 g/kg), and (50, 100 g/kg) exhibited significant effect (P < 0.01, P < 0.05) in latency time of 15, 30, and 60 min, while compounds and (100 g/kg) exhibited significant effect (P < 0.01, P < 0.05) in latency time interval of 15 and 30 min. Compounds , , and showed moderate activity. Among the tested hits, compounds (17.3 ± 2.2), (16.2 ± 2.1), and (16.1 ± 2.1) showed significant anti-nociceptive potential. Molecular docking studies on the most active anti-nociceptive hits indicated that the activity might be attributed to the ability of the compounds to target μ-opioid receptor (μOR) effectively. Furthermore, compounds and showed anti-bacterial activity against and with MIC of 40.97 and 54.77 g/mL, respectively. In addition, the predicted ADMET profile of , , and indicates that these molecules follow the drug-likeness criteria, and their activity can be enhanced through structural optimization.
通过一锅法合成了一系列新的硫代二嗪硫酮,包括5-(2-羟乙基)-3-烷基/芳基-1,3,5-硫代二嗪-2-硫酮(-)、5-(2-羟丙基)-3-烷基/芳基-1,3,5-硫代二嗪-2-硫酮(-)、3,5-二丙基-1,3,5-硫代二嗪-2-硫酮()和(2-(5-烷基/芳基-6-硫代-1,3,5-硫代二嗪-3-基)烷基乙酸酯/苯甲酸酯)(-)。通过核磁共振和质谱对合成化合物的结构进行了表征。采用热板法在BALB/C小鼠上进行化合物的抗伤害感受活性实验,其中化合物、(50 g/kg)和(50、100 g/kg)在15、30和60分钟的潜伏时间上表现出显著效果(P < 0.01,P < 0.05),而化合物和(100 g/kg)在15和30分钟的潜伏时间间隔上表现出显著效果(P < 0.01,P < 0.05)。化合物、和表现出中等活性。在测试的命中化合物中,化合物(17.3 ± 2.2)、(16.2 ± 2.1)和(16.1 ± 2.1)表现出显著的抗伤害感受潜力。对活性最强的抗伤害感受命中化合物进行分子对接研究表明,该活性可能归因于化合物有效靶向μ-阿片受体(μOR)的能力。此外,化合物和对和表现出抗菌活性,最低抑菌浓度分别为40.97和54.77 g/mL。此外,、和的预测ADMET谱表明这些分子符合类药标准,并且可以通过结构优化提高它们的活性。